The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells

Biomaterials

Volumn 34, Issue 9, 2013, Pages 2359-2369

  Koppolu, Bhanuprasanth ^a   Zaharoff, David A ^a  

^a University of Arkansas   (United States)

Author keywords

Adjuvant; Antigen delivery; Antigen presentation; Chitosan particles; Co stimulation

Indexed keywords

ADJUVANT; ANTIGEN DELIVERY; ANTIGEN PRESENTATION; CHITOSAN PARTICLES; CO-STIMULATION;

BIOMATERIALS; CHITOSAN; DATA ENCAPSULATION; POLYPEPTIDES; PRECIPITATION (CHEMICAL);

ANTIGENS;

ANTIGEN; BOVINE SERUM ALBUMIN; CHITOSAN; FLUORESCEIN ISOTHIOCYANATE; OVALBUMIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; COACERVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENCAPSULATION; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; BIOCOMPATIBLE MATERIALS; CELL LINE; CELL PROLIFERATION; CHITOSAN; DENDRITIC CELLS; MACROPHAGES; MICE; OVALBUMIN; PARTICLE SIZE; SERUM ALBUMIN;

BOVINAE;

EID: 84872397477     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.066     Document Type: Article

References (38)

1. O'Hagan D.T., Singh M., Ulmer J.B. Microparticle-based technologies for vaccines. Methods 2006, 40:10-19.
2. O'Hagan D.T., Valiante N.M. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003, 2:727-735.
3. Clark T.G., Cassidy-Hanley D. Recombinant subunit vaccines: potentials and constraints. Dev Biol (Basel) 2005, 121:153-163.
4. Schlom J., Gulley J.L., Arlen P.M. Paradigm shifts in cancer vaccine therapy. Exp Biol Med (Maywood) 2008, 233:522-534.
5. Schlom J., Gulley J.L., Arlen P.M. Role of vaccine therapy in cancer: biology and practice. Curr Oncol 2007, 14:238-245.
6. Qu B., Rosenberg R.N., Li L., Boyer P.J., Johnston S.A. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol 2004, 61:1859-1864.
7. Perrie Y., Mohammed A.R., Kirby D.J., McNeil S.E., Bramwell V.W. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 2008, 364:272-280.
8. Morein B., Villacres-Eriksson M., Sjolander A., Bengtsson K.L. Novel adjuvants and vaccine delivery systems. Vet Immunol Immunopathol 1996, 54:373-384.
9. O'Hagan D.T., Rappuoli R. Novel approaches to vaccine delivery. Pharm Res 2004, 21:1519-1530.
10. He C., Hu Y., Yin L., Tang C., Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010, 31:3657-3666.
11. Thiele L., Rothen-Rutishauser B., Jilek S., Wunderli-Allenspach H., Merkle H.P., Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J Control Release 2001, 76:59-71.
12. Scheicher C., Mehlig M., Dienes H.P., Reske K. Uptake of bead-adsorbed versus soluble antigen by bone marrow derived dendritic cells triggers their activation and increases their antigen presentation capacity. Adv Exp Med Biol 1995, 378:253-255.
13. Scheicher C., Mehlig M., Dienes H.P., Reske K. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 1995, 25:1566-1572.
14. Singh M., Chakrapani A., O'Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines 2007, 6:797-808.
15. Pearse M.J., Drane D. ISCOMATRIX adjuvant for antigen delivery. Adv Drug Deliv Rev 2005, 57:465-474.
16. Zaharoff D.A., Hance K.W., Rogers C.J., Schlom J., Greiner J.W. Intratumoral immunotherapy of established solid tumors with chitosan/IL-12. J Immunother 2010, 33:697-705.
17. Zaharoff D.A., Hoffman B.S., Hooper H.B., Benjamin C.J., Khurana K.K., Hance K.W., et al. Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res 2009, 69:6192-6199.
18. Zaharoff D.A., Rogers C.J., Hance K.W., Schlom J., Greiner J.W. Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine 2007, 25:8673-8686.
19. Zaharoff D.A., Rogers C.J., Hance K.W., Schlom J., Greiner J.W. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 2007, 25:2085-2094.
20. Arca H.C., Gunbeyaz M., Senel S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 2009, 8:937-953.
21. Bernkop-Schnurch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 2000, 194:1-13.
22. Kreuter J. Nanoparticles and microparticles for drug and vaccine delivery. J Anat 1996, 189(Pt 3):503-505.
23. van der Lubben I.M., Verhoef J.C., Borchard G., Junginger H.E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 2001, 14:201-207.
24. Berthold A., Cremer K., Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs. J Control Release 1996, 39:17-25.
25. Gan Q., Wang T. Chitosan nanoparticle as protein delivery carrier - systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007, 59:24-34.
26. Ozbas-Turan S., Akbuga J., Aral C. Controlled release of interleukin-2 from chitosan microspheres. J Pharm Sci 2002, 91:1245-1251.
27. Gordon S., Saupe A., McBurney W., Rades T., Hook S. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. J Pharm Pharmacol 2008, 60:1591-1600.
28. Nagamoto T., Hattori Y., Takayama K., Maitani Y. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 2004, 21:671-674.
29. van der Lubben I.M., Verhoef J.C., Borchard G., Junginger H.E. Chitosan for mucosal vaccination. Adv Drug Deliv Rev 2001, 52:139-144.
30. Inaba K., Swiggard W.J., Steinman R.M., Romani N., Schuler G., Brinster C. Isolation of dendritic cells. Curr Protoc Immunol 2009, Chapter 3: Unit 3, 7.
31. Harush-Frenkel O., Rozentur E., Benita S., Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 2008, 9:435-443.
32. Pan Y., Li Y.J., Zhao H.Y., Zheng J.M., Xu H., Wei G., et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002, 249:139-147.
33. Shanbhag A.S., Jacobs J.J., Black J., Galante J.O., Glant T.T. Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res 1994, 28:81-90.
34. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
35. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
36. Elamanchili P., Diwan M., Cao M., Samuel J. Characterization of poly(D, L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 2004, 22:2406-2412.
37. Sharp F.A., Ruane D., Claass B., Creagh E., Harris J., Malyala P., et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A 2009, 106:870-875.
38. Chang K.L., Higuchi Y., Kawakami S., Yamashita F., Hashida M. Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape. Bioconjug Chem 2010, 21:1087-1095.